Global Men’s Health Market, By Application (Male Hypogonadism Therapy, Prostate Cancer Therapy, Erectile Dysfunction Therapy, Premature Ejaculation Therapy and Others), End Use (Hospitals, Diagnostic Centers, Clinics and Others) – Industry Trends and Forecast to 2029.
Global Men’s Health Market Analysis and Size
Improving the overall quality of healthcare services is an important initiative. Providing the best of healthcare services ensures offering better management of diseases and disorders. Male population too suffers numerous problems most of which they are shy of talking about. But with the rising awareness about personal health, the market is set to grow in the future.
Data Bridge Market Research analyses that the men’s health market is expected to undergo a CAGR of 15.00% during the forecast period. “Hospitals” dominates the end use segment of the men’s health market owing to the growing number of hospitals especially in the developing economies.
Global Men’s Health Market Definition
From the name itself, it is clear that men’s health refers to a medical procedure that involves providing therapeutics, drugs, precautionary measures against diseases and infections and surgical offerings to the male population of patients. Men’s heath is concerned with improving the overall health of male population.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Application (Male Hypogonadism Therapy, Prostate Cancer Therapy, Erectile Dysfunction Therapy, Premature Ejaculation Therapy and Others), End Use (Hospitals, Diagnostic Centers, Clinics and Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
Novartis AG (Switzerland), Pfizer Inc. (US), Merck & Co., Inc. (Germany), Novo Nordisk A/S (Denmark), Amgen Inc. (US), Lupin Pharmaceuticals, Inc. (India), AstraZeneca (UK), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Ferring B.V. (Switzerland), Abbott (US), Bausch & Lomb Incorporated (US), Vertical Pharmaceuticals, LLC (US), Veru Inc. (US), BD (US) and AbbVie Inc. (US)
Men’s Health Market Dynamics
Rising Prevalence of Conditions
Growing incidence rate of several male conditions globally is one of the major factors fostering the growth of the market. Increasing incidence rate of hypogonadism therapy, prostate cancer therapy, erectile dysfunction therapy, premature ejaculation therapy and others is directly propelling the market growth rate.
Research and Development Proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the advancements in medical technologies and devices is also bolstering the market growth rate.
Growing Investment for Healthcare Facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Furthermore, upsurge in the public-private funding for target research activities, high stress levels in young people and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, unhealthy lifestyle of individuals, rising internet penetration rate, ongoing product development and commercialization and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/Challenges Global Men’s Health Market
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services, dearth of skilled medical professionals and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, high costs associated with the procedure, limited insurance coverage and regulatory compliance, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
This men’s health market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the men’s health market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Men’s Health Market
The COVID-19 pandemic essentially affected the market. This is because of the fact that majority of the healthcare resources were directed towards meeting the demand arising out of COVID-19 patients. Postponement of non-elective surgeries and non-essential healthcare procedures has further derailed the market growth rate in this pandemic period. Further, restrictions imposed on travel owing to the lockdown regulations further challenged the market growth rate in this period. However, the post pandemic period will help to generate profits and revenues.
- In March 2021, Procter & Gamble brand, Gillette launched the first razor Gillette SkinGuard Sensitive designed especially for men with sensitive skin to the luxurious GilletteLabs Heated Razor collection.
- In March 2021, Lumin, a manufacturer of men's skincare products, has introduced a skin moisturizer with SPF protection, the UV-defense moisturizing balm, which is both sustainable and free of dangerous chemicals.
- In October 2021, Vedix, a customized ayurvedic beauty brand in India, announced the entry into the men’s skincare category with men grooming range of products such as face wash, moisturizer, and overnight serum.
Global Men’s Health Market Scope
The men’s health market is segmented on the basis of application and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Male Hypogonadism Therapy
- Prostate Cancer Therapy
- Erectile Dysfunction Therapy
- Premature Ejaculation Therapy
Based on product, the men’s health market is segmented into male hypogonadism therapy, prostate cancer therapy, erectile dysfunction therapy, premature ejaculation therapy and others.
- Diagnostic Centers
Men’s health market has also been segmented based on the end use into hospitals, diagnostic centers, clinics and others.
Men’s Health Market Regional Analysis/Insights
The men’s health market is analysed and market size insights and trends are provided by country, application and end use as referenced above.
The countries covered in the men’s health market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the men’s health market because of the strong base of healthcare facilities, widespread utilization of medications, increasing consciousness regarding the essence of maintaining good health and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, increasing of the incidences of osteoarthritis, infertility, and other disorders large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The men’s health market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for men’s health market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the men’s health market. The data is available for historic period 2010-2020.
Competitive Landscape and Men’s Health Market Share Analysis
The men’s health market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to men’s health market.
Some of the major players operating in the men’s health market are:
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Merck & Co., Inc. (Germany)
- Novo Nordisk A/S (Denmark)
- Amgen Inc. (US)
- Lupin Pharmaceuticals, Inc. (India)
- AstraZeneca (UK)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Sanofi (France)
- Johnson & Johnson Services, Inc. (US)
- GlaxoSmithKline plc (UK)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (US)
- Ferring B.V. (Switzerland)
- Abbott (US)
- Bausch & Lomb Incorporated (US)
- Vertical Pharmaceuticals, LLC (US)
- Veru Inc. (US)
- BD (US)
- AbbVie Inc. (US)